Ranbaxy Laboratories Limited

It was just several years ago when Daiichi Sankyo Co., Ltd. ’s first antibody-drug conjugate (ADC) Enhertu (trastuzumab deruxtecan) was launched in the US, helped by the Japanese company’s largest co

George Nakayama, the former president and CEO of Daiichi Sankyo Co., Ltd. , is the executive who made two fate-changing decisions for the major Japanese firm. The first one was to focus its R&D resou

Aurobindo Pharma Limited plans to use economies of scale to differentiate its fledgling Contract Development and Manufacturing Organization (CDMO) Theranym Biologics Pvt Ltd from its Indian counterpa

Astellas Pharma is changing gears in India, led by its gritty woman chief, who has moved up the ranks in the industry acing multiple roles along the way, including some in yesteryear’s traditional ma